Advertisement

The Nutshell

» NIH and disease/medicine

Daily News Roundup

Most Recent

image: Obama’s Budget Seeks Science Boost

Obama’s Budget Seeks Science Boost

By | February 2, 2015

Fiscal year 2016 could be very bright for the research enterprise if the President’s budgetary requests are granted.

1 Comment

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

image: Ebola Update

Ebola Update

By | January 26, 2015

Vaccine trial to start in Liberia as early as next week; trial for experimental therapy also planned, but production is still limited

1 Comment

image: Toward a Cocaine Vaccine

Toward a Cocaine Vaccine

By | January 22, 2015

A modified bacterial protein elicits a robust immune response against a cocaine-linked molecule in mice.

0 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Ebola Update

Ebola Update

By | January 12, 2015

Researchers gear up for efficacy trials of experimental Ebola vaccines in Africa.

0 Comments

image: Funding Turnaround?

Funding Turnaround?

By | January 12, 2015

The National Institutes of Health saw a slight improvement in success rate for R01 or equivalent grants last year.

3 Comments

image: Trainee Raise

Trainee Raise

By | January 12, 2015

Grad students and postdoctoral fellows supported by US National Institutes of Health National Research Service Awards land a 2 percent stipend bump in 2015.

2 Comments

image: Growing Human Guts in Mice

Growing Human Guts in Mice

By | January 12, 2015

Researchers make more progress toward growing human intestines in mice, paving the way for better models of intestinal function and failure.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

Advertisement

Popular Now

  1. Judge Decides on GM Rice Retraction
  2. Ancient Viruses as Gene Therapy Vectors
  3. The Prescient Placenta
    Features The Prescient Placenta

    The maternal-fetal interface plays important roles in the health of both mother and baby, even after birth.

  4. Inspired by Nature
    Features Inspired by Nature

    Researchers are borrowing designs from the natural world to advance biomedicine.

Advertisement
Cell Sciences
Cell Sciences
Advertisement
Life Technologies